This conflicting discrepancy might be connected to the availability of nutrients in tumor microenvironments, as adiponectin was found to promote colorectal cancer survival in glucose deprivation but produce inhibitory action in the presence of high glucose levels [88]. Here, ADIPOQ is linked to colorectal cancer.